vimarsana.com

Page 3 - தடுப்பூசி ப்ரொக்யூர்மெஂட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Are You Asking States to Compete for Vaccines? : SC Raps Centre Over Dual Pricing Policy

The apex court also posed several questions to the Centre on the need for mandatory registration on CoWIN app, and the differential treatment of people based on age groups for vaccination.

India should fully centralise jab procurement, set up vaccine commission to decide interstate allocation: EY

India should fully centralise jab procurement, set up vaccine commission to decide interstate allocation: EY SECTIONS Share Synopsis Centralised vaccine procurement would keep costs to a minimum since a single agency for purchase would be able to reap economies of scale and have much better bargaining power in the domestic and international markets, said DK Srivastava, EY India chief policy advisor, in the report. Agencies India vaccinated 1.9 million people on Wednesday taking the total figure to 202 million, official data showed. India should follow a completely centralised Covid-19 vaccine procurement policy to minimise costs with a vaccination commission to oversee interstate vaccine allocation and pricing, EY said in a report on Thursday.

Centre should procure vaccine through global tender: Kerala CM Pinarayi Vijayan

Centre should procure vaccine through global tender: Kerala CM Pinarayi Vijayan SECTIONS Last Updated: May 24, 2021, 10:20 PM IST Share Synopsis The Chief Minister said, “We cannot proceed with the planned pace of the vaccination due to the scarcity of the vaccine. The state government has called for a global tender for the purchase of vaccines to address this shortage. But inviting tenders by State governments could lead to a sharp rise in the price of vaccines. Therefore, the price of vaccines can be kept low if the central government calls for a global tender to purchase the vaccine that is needed for the country as a whole, taking into account the vaccine demand of each state.

Top news of the day: Government says COVID-19 positive test not mandatory for hospital admission; DRDO-developed anti-COVID drug approved for emergency use, and more

The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. In his virtual address at the 25th meeting of the Group of Ministers, the Health Minister said, “180 districts have showed no fresh cases in the last seven days, 18 districts in 14 days, 54 districts in 21 days and 32 districts were bereft of any fresh cases in the last 28 days.” He said that across the country, the number of patients in ICU beds is 4,88,861 while 1,70,841 patients were on ventilators and 9,02,291 patients were on oxygen support.

Seven measures still up for Duterte s signature

Seven measures still up for Duterte’s signature Published April 19, 2021 11:08am Seven proposed measures are still pending for President Rodrigo Duterte s approval, a list from the Senate showed on Monday. According to the list, which indicated the performance of the Senate during the second regular session of the 18th Congress, the seven measures waiting for Duterte s signature include significant ones such as: S.No. 1563 - Lowering The Minimum Height Requirement for Applicants of the Philippine National Police (PNP), Bureau of Fire Protection (BFP), Bureau of Jail Management and Penology (BJMP), And Bureau of Correction (BuCor), Amending Republic Act No. 6975, As Amended, Republic Act No. 9263, And Republic Act No. 10575; and

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.